Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients

BACKGROUND: Elagolix is an oral, gonadotropin-releasing hormone (GnRH) receptor antagonist, that significantly reduces dysmenorrhea and non-menstrual pelvic pain (NMPP) in women with moderate to severe endometriosis-associated pain. METHODS: Data were pooled from two 6-month, placebo-controlled, pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrao, Mauricio S., Surrey, Eric, Gordon, Keith, Snabes, Michael C., Wang, Hui, Ijacu, Horia, Taylor, Hugh S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210385/
https://www.ncbi.nlm.nih.gov/pubmed/34134684
http://dx.doi.org/10.1186/s12905-021-01385-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210385/
https://www.ncbi.nlm.nih.gov/pubmed/34134684
http://dx.doi.org/10.1186/s12905-021-01385-3

Ejemplares similares